The imposed insurance for medical care will in some cases integrate mobile medical applications into the healthcare system.
Manufacturers / distributors of mobile medical applications can do a notification to integrate their mobile medical application into existing or new care processes if they offer a benefit or added value. More Info.
The intention is not to reimburse applications per se, but their use within the context of a specific care process. To embrace the use of such digital health technology and increase adoption, it is almost always necessary to innovate the financing of such a care process. This will therefore happen step by step and gradually more and more care processes and their financing will be adapted to today's needs and possibilities. This financing can be temporary or permanent.
The temporary reimbursement is for applications of an innovative nature, for which there is already evidence, but some uncertainties remain. This will be shown as M3 light = M3-.
When the use of mobile medical applications is definitively integrated into the financing of the care process, it will be indicated as M3+.
Below you will find a list of care processes that already qualify and within which applications can be reimbursed.
Care processes in which applications are temporarily reimbursed (M3 light):
Care processes in which applications are definitively reimbursed (M3 plus):
- Ambulant follow-up of cancer patients. (In the making)
- Holter recording for cardiac patients. (In the making)
- Telemonitoring for heart failure patients. (In the making)
- Telemonitoring for OSA patients (sleep apnea). (In the making)
You can read more details about this per care process by clicking on the corresponding link, including about the purpose, who is eligible and how the reimbursement is made.